An economic evaluation of colesevelam when added to metformin-, insulin- or sulfonylurea-based therapies in patients with uncontrolled type 2 diabetes mellitus.

Simons, W Robert

An economic evaluation of colesevelam when added to metformin-, insulin- or sulfonylurea-based therapies in patients with uncontrolled type 2 diabetes mellitus. [electronic resource] - PharmacoEconomics 2010 - 765-80 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1179-2027

10.2165/11539600-000000000-00000 doi


Adult
Aged
Allylamine--administration & dosage
Cardiovascular Diseases--economics
Cholesterol, LDL--blood
Colesevelam Hydrochloride
Cost-Benefit Analysis--methods
Databases, Factual
Diabetes Complications--economics
Diabetes Mellitus, Type 2--blood
Drug Therapy, Combination--economics
Female
Glycated Hemoglobin--metabolism
Health Care Costs
Humans
Hypercholesterolemia--blood
Insulin--administration & dosage
Male
Metformin--administration & dosage
Middle Aged
Models, Economic
Randomized Controlled Trials as Topic
Risk
Sulfonylurea Compounds--administration & dosage
Treatment Outcome
United States